Press Releases

Date Title and Summary Additional Formats
11/06/17 Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 27, 2017, to stockholders of record at the
View HTML
11/06/17 Phibro Animal Health Corporation Reports First Quarter
  TEANECK, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2017. Highlights for the September 2017 quarter (compared to the September 2016 quarter) Net sales of $193 million, an
View HTML
10/16/17 Phibro Animal Health Corporation to Participate in the Credit Suisse Healthcare Conference
TEANECK, N.J., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Credit Suisse Healthcare Conference.
View HTML
10/03/17 Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2017 Quarterly Financial Results
TEANECK, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review its first quarter financial results. Phibro expects to issue a news release containing quarterly results after the market closes on Monday, November 6,
View HTML
09/12/17 Phibro Animal Health Corporation to Acquire Biotay S.A. in Argentina View HTML
08/30/17 Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
      TEANECK, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2017. Highlights for the June 2017 quarter (compared to the June 2016 quarter) Net sales of $195 million,
View HTML
08/09/17 Phibro Animal Health Corporation to Participate in the Morgan Stanley 2017 Global Healthcare Conference
TEANECK, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chief Financial Officer Richard Johnson and Director and Executive Vice President, Corporate Strategy, Daniel Bendheim will address financial analysts and investors at the Morgan Stanley 2017 Global
View HTML
07/24/17 Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J., July 24, 2017 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 27, 2017, to stockholders of record at the
View HTML
07/06/17 Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2017 Results
TEANECK, N.J., July 06, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review fourth quarter and fiscal year 2017 financial results, discuss fiscal year 2018 financial guidance and respond to questions from investors.
View HTML
07/05/17 Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's Poultry Vaccine Technologies
TEL AVIV, Israel and AHMEDABAD, India, July 05, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:PAHC) Phibro Animal Health Corporation and Zydus Cadila today announced their intention to enter into a long-term arrangement to license Phibro's innovative poultry vaccine technologies and know-how to a new vaccine
View HTML